Mouat, Isobel C, Zhu, Li, Aslan, Alperen et al. · Journal of inflammation (London, England) · 2024 · DOI
This study looked at whether Epstein-Barr virus (EBV), a common virus that stays dormant in most people's bodies, reactivates in stroke patients who experience severe fatigue. Researchers compared 44 stroke survivors—22 with high fatigue and 22 with low fatigue—and measured both the amount of active virus and antibodies against it in their blood. While they found that EBV reactivation happened equally in both groups, people with high fatigue showed unusual patterns in their immune response to the virus, suggesting their bodies may not be fighting EBV normally.
ME/CFS researchers have documented abnormal EBV antibody responses in patients, making this investigation of antibody dysregulation—independent of active viral reactivation—potentially relevant to understanding post-viral fatigue mechanisms. The finding that fatigue-related immune dysfunction can exist without detectable viral reactivation suggests novel pathways of EBV-associated pathology that may apply across fatigue-associated conditions.
This study does not prove that EBV causes post-stroke fatigue; the aberrant antibody response could be a consequence rather than a cause of fatigue. The small sample size (n=44) and cross-sectional design prevent establishing temporal relationships or causal mechanisms. Results cannot be generalized to acute stroke, ME/CFS populations, or other post-viral fatigue conditions without additional research.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.